ARTICLE | Clinical News
Zelrix regulatory update
November 8, 2010 8:00 AM UTC
NuPathe submitted an NDA to FDA for Zelrix to treat migraines. The company expects a PDUFA date in 2H11. Zelrix is a transdermal patch delivering sumatriptan via iontophoresis. ...